Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
There is currently no completely effective therapy available for metastatic pheochromocytomas or paragangliomas. Increasing understanding of the germline and somatic mutations leading to pheochromocytoma and paraganglioma development has revealed crucial insights into the molecular pathology of thes...
Κύριοι συγγραφείς: | Nölting, S, Grossman, AB |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2012
|
Παρόμοια τεκμήρια
-
Pheochromocytomas and paragangliomas: assessment of malignant potential.
ανά: Korevaar, T, κ.ά.
Έκδοση: (2011) -
Pheochromocytomas and paragangliomas: assessment of malignant potential
ανά: Korevaar, T, κ.ά.
Έκδοση: (2011) -
Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine
ανά: Nölting, S, κ.ά.
Έκδοση: (2019) -
Pheochromocytomas and secreting paragangliomas
ανά: Gimenez-Roqueplo Anne-Paule, κ.ά.
Έκδοση: (2006-12-01) -
Treatment of metastatic pheochromocytoma and paraganglioma with I-131-meta-iodobenzylguanidine (MIBG)
ανά: Kaltsas, G, κ.ά.
Έκδοση: (2003)